This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Modality Solutions, a full-service cold chain biopharmaceutical engineering firm, is pleased to announce the addition of Matthew Coker to its growing engineering team. Matthew brings a technical emphasis on cellular and biomolecular engineering as it relates to regenerative medicine to his new position as a Modality Solutions consulting engineer.
According to Precedence Research, the regenerative medicine market size is expected to hit around $23.7 billion by 2027, growing at a compound annual growth rate of 16.1% from 2020 to 2027. Factors such as the increasing prevalence of chronic disorders and genetic disorders, the rising popularity of stem cells, and a growing number of trauma emergencies are driving the growth of the regenerative medicine market.
Matthew’s consulting engineer responsibilities include design and validation engineering services for the life sciences industry. He strategically creates the proper validation strategy for a client’s cold chain systems through risk and gap analysis. In addition, he designs and executes validation master plans by creating standard operating procedures and qualifying critical equipment and thermal packaging.
